Recombinant DNA Derived Monomeric Insulin Analogue: Comparison With Soluble Human Insulin in Normal Subjects.

BMJ
doi 10.1136/bmj.297.6658.1236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Human Insulin Prepared by Recombinant DNA Techniques and Native Human Insulin Interact Identically With Insulin Receptors.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Effects of Recombinant Insulin-Like Growth Factor I on Insulin Secretion and Renal Function in Normal Human Subjects.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Miscibility of Human and Bovine Ultralente Insulin With Soluble Insulin.

BMJ
1984English

Effects of Sc Administration of Recombinant Human Insulin-Like Growth Factor I (IGF-I) on Normal Human Subjects.

Endocrinologia Japonica
1990English

Pharmacological and Clinical Profiles of New Soluble Basal Insulin Analogue, Insulin Detemir (Levemir®)

Folia Pharmacologica Japonica
Pharmacology
2008English

Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Insulin Delivery Rate Into Plasma in Normal and Diabetic Subjects

Journal of Clinical Investigation
Medicine
1968English

Insulin Delivery Rate Into Plasma in Normal and Diabetic Subjects

Journal of Clinical Investigation
Medicine
1968English

Recombinant Human Insulin-Like Growth Factor I (rhIGF I) Reduces Hyperglycaemia in Patients With Extreme Insulin Resistance

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy